A detailed history of Cubic Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cubic Asset Management, LLC holds 975 shares of AMGN stock, worth $256,600. This represents 0.07% of its overall portfolio holdings.

Number of Shares
975
Previous 975 -0.0%
Holding current value
$256,600
Previous $280,000 1.07%
% of portfolio
0.07%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

SELL
$255.7 - $288.46 $5,114 - $5,769
-20 Reduced 2.01%
975 $280,000
Q2 2023

Jul 31, 2023

BUY
$214.27 - $253.37 $1,071 - $1,266
5 Added 0.51%
995 $220,000
Q4 2022

Jan 30, 2023

SELL
$229.03 - $291.01 $4,580 - $5,820
-20 Reduced 1.98%
990 $260,000
Q4 2021

Jan 24, 2022

SELL
$198.88 - $227.6 $2,585 - $2,958
-13 Reduced 1.27%
1,010 $227,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $286,139 - $335,247
-1,348 Reduced 56.85%
1,023 $218,000
Q3 2021

Oct 25, 2021

BUY
$212.27 - $248.7 $286,139 - $335,247
1,348 Added 131.77%
2,371 $347,000
Q2 2021

Jul 23, 2021

BUY
$233.58 - $259.14 $1,401 - $1,554
6 Added 0.59%
1,023 $249,000
Q4 2020

Jan 28, 2021

SELL
$216.38 - $257.67 $2,380 - $2,834
-11 Reduced 1.07%
1,017 $234,000
Q1 2020

Apr 27, 2020

SELL
$182.24 - $241.7 $91,120 - $120,850
-500 Reduced 32.72%
1,028 $208,000
Q4 2019

Jan 24, 2020

SELL
$189.21 - $243.2 $1,892 - $2,432
-10 Reduced 0.65%
1,528 $368,000
Q2 2019

Jul 29, 2019

SELL
$166.7 - $195.41 $25,005 - $29,311
-150 Reduced 8.89%
1,538 $283,000
Q1 2019

Apr 29, 2019

SELL
$180.87 - $203.88 $62,400 - $70,338
-345 Reduced 16.97%
1,688 $321,000
Q4 2018

Jan 28, 2019

SELL
$178.4 - $208.25 $2,319 - $2,707
-13 Reduced 0.64%
2,033 $396,000
Q4 2017

Jan 24, 2018

SELL
$168.79 - $188.59 $2,531 - $2,828
-15 Reduced 0.73%
2,046 $356,000
Q3 2017

Oct 26, 2017

BUY
$167.29 - $191.0 $344,784 - $393,651
2,061
2,061 $384,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cubic Asset Management, LLC Portfolio

Follow Cubic Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubic Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubic Asset Management, LLC with notifications on news.